SCM
DRNA

Silverarc Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Silverarc Capital Management’s Portfolio DRNA Stock Details DRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-31,040
Closed -$626K – 98
2021
Q3 		$626K Sell
31,040
-198,852
-86% -$5.49M 0.36% 63
2021
Q2 		$8.58K Buy
229,892
+29,892
+15% +$916K 4.19% 3
2021
Q1 		$5.11M Sell
200,000
-27,388
-12% -$700K 2.87% 8
2020
Q4 		$5.01M Buy
+227,388
New +$5.01M 3.06% 7

Other funds holding DRNA

CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return